Armodafinil in Reducing Cancer-Related Fatigue in Patients With High Grade Glioma

NCT01781468 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

328

Enrollment

OTHER

Sponsor class

Conditions

Fatigue

Interventions

DRUG: armodafinil 150 mg
OTHER: Placebo
DRUG: armodafinil 250 mg

Sponsor

Alliance for Clinical Trials in Oncology

Collaborators

[object Object]